These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 26480684)

  • 1. [Animal model of neuromyelitis optica].
    Okuno T; Kinoshita M; Nakatsuji Y; Mochizuki H
    Nihon Rinsho; 2015 Sep; 73 Suppl 7():81-9. PubMed ID: 26480684
    [No Abstract]   [Full Text] [Related]  

  • 2. Features of neuromyelitis optica spectrum disorders with aquaporin-4 and myelin-oligodendrocyte glycoprotein antibodies.
    Gao J; Pan W; Zhang H
    JAMA Neurol; 2014 Jul; 71(7):923-4. PubMed ID: 25023552
    [No Abstract]   [Full Text] [Related]  

  • 3. Features of neuromyelitis optica spectrum disorders and aquaporin-4 with myelin-oligodendrocyte glycoprotein antibodies-reply.
    Kitley J; Waters P; Vincent A; Palace J
    JAMA Neurol; 2014 Jul; 71(7):924. PubMed ID: 25023554
    [No Abstract]   [Full Text] [Related]  

  • 4. Clinical features and long-term outcome of a group of Japanese children with inflammatory central nervous system disorders and seropositivity to myelin-oligodendrocyte glycoprotein antibodies.
    Hino-Fukuyo N; Haginoya K; Nakashima I; Sato DK; Takahashi T; Misu T; Fujihara K; Hirose M; Kakisaka Y; Uematsu M; Kobayashi T; Kure S
    Brain Dev; 2015 Oct; 37(9):849-52. PubMed ID: 25748628
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Does aquaporin-4-seronegative neuromyelitis optica exist?
    Levy M
    JAMA Neurol; 2014 Mar; 71(3):271-2. PubMed ID: 24424919
    [No Abstract]   [Full Text] [Related]  

  • 6. [MRI and CSF features in neuromyelitis optica].
    Misu T
    Nihon Rinsho; 2015 Sep; 73 Suppl 7():277-82. PubMed ID: 26480713
    [No Abstract]   [Full Text] [Related]  

  • 7. The two faces of neuromyelitis optica.
    Weinshenker BG; Wingerchuk DM
    Neurology; 2014 Feb; 82(6):466-7. PubMed ID: 24415570
    [No Abstract]   [Full Text] [Related]  

  • 8. [Experimental models of neuromyelitis optica].
    Lassmann H
    Rinsho Shinkeigaku; 2009 Nov; 49(11):900-1. PubMed ID: 20030243
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuromyelitis optica spectrum disorders with aquaporin-4 and myelin-oligodendrocyte glycoprotein antibodies: a comparative study.
    Kitley J; Waters P; Woodhall M; Leite MI; Murchison A; George J; Küker W; Chandratre S; Vincent A; Palace J
    JAMA Neurol; 2014 Mar; 71(3):276-83. PubMed ID: 24425068
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-aquaporin-4 auto-antibodies orchestrate the pathogenesis in neuromyelitis optica.
    Saikali P; Cayrol R; Vincent T
    Autoimmun Rev; 2009 Dec; 9(2):132-5. PubMed ID: 19389490
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MOG-IgG in neuromyelitis optica.
    Luppe S; Robertson NP
    J Neurol; 2014 Mar; 261(3):640-2. PubMed ID: 24532204
    [No Abstract]   [Full Text] [Related]  

  • 12. [Pathogenesis of Neuromyelitis Optica: aquaporin 4 autoimmunity and astrocytopathy].
    Misu T; Fujihara K; Takahashi T; Takano R; Nishiyama S; Takai Y; Nakashima I; Sato S; Lassmann H; Itoyama Y
    Rinsho Shinkeigaku; 2010 Nov; 50(11):872. PubMed ID: 21921482
    [No Abstract]   [Full Text] [Related]  

  • 13. Author response.
    Sato DK; Takahashi T; Waters PJ; Fujihara K
    Neurology; 2014 Jul; 83(5):475-6. PubMed ID: 25215376
    [No Abstract]   [Full Text] [Related]  

  • 14. Author response.
    Sato DK; Callegaro D; Lana-Peixoto MA; Horizonte B; Nakashima I; Fujihara K
    Neurology; 2014 Sep; 83(12):1122-3. PubMed ID: 25356464
    [No Abstract]   [Full Text] [Related]  

  • 15. [Clinical concept, etiology and pathology of neuromyelitis optica].
    Kurosawa K; Fujihara K
    Nihon Rinsho; 2014 Nov; 72(11):1897-902. PubMed ID: 25518368
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Severe demyelination but no astrocytopathy in clinically definite neuromyelitis optica with anti-myelin-oligodendrocyte glycoprotein antibody.
    Ikeda K; Kiyota N; Kuroda H; Sato DK; Nishiyama S; Takahashi T; Misu T; Nakashima I; Fujihara K; Aoki M
    Mult Scler; 2015 Apr; 21(5):656-9. PubMed ID: 25257613
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Persisting myelin oligodendrocyte glycoprotein antibodies in aquaporin-4 antibody negative pediatric neuromyelitis optica.
    Rostásy K; Mader S; Hennes EM; Schanda K; Gredler V; Guenther A; Blaschek A; Korenke C; Pritsch M; Pohl D; Maier O; Kuchukhidze G; Brunner-Krainz M; Berger T; Reindl M
    Mult Scler; 2013 Jul; 19(8):1052-9. PubMed ID: 23257621
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comment on severe demyelination but no astrocytopathy in clinically definite neuromyelitis optica with anti-myelin-oligodendrocyte glycoprotein antibody.
    Arrambide G; Tur C; Montalban X
    Mult Scler; 2015 Apr; 21(5):660-1. PubMed ID: 25662350
    [No Abstract]   [Full Text] [Related]  

  • 19. [Diagnostic criteria and differential diagnosis of neuromyelitis optica].
    Nakashima I
    Nihon Rinsho; 2014 Nov; 72(11):1964-9. PubMed ID: 25518378
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Distinction between MOG antibody-positive and AQP4 antibody-positive NMO spectrum disorders.
    Kezuka T; Tanaka K; Matsunaga Y; Goto H
    Neurology; 2014 Jul; 83(5):475. PubMed ID: 25074893
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.